Concepedia

Ross G. Vickery

RG

Statistics

Publications

17

Citations

823

H-Index

12

Active since

1988

Affiliations

Theravance Biopharma (United States)(Current)

Stanford University

United States Department of Veterans Affairs

DS Biopharma (Ireland)

University of California, San Francisco

Ross G. Vickery is an author at Theravance Biopharma (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

MedicinePharmacologyPharmacotherapyDrug DiscoveryNeuropharmacologyMolecular PharmacologyAnesthesiologyAnesthesiaPhysiologyNeuroscience

Publications per year

1988–2021

17

Publications

17

Distinct Dynamin-dependent and -independent Mechanisms Target Structurally Homologous Dopamine Receptors to Different Endocytic Membranes

Ross G. Vickery, Mark von Zastrow · The Journal of Cell Biology · 1999 · 233 citations · Full text

Dexmedetomidine Diminishes Halothane Anesthetic Requirements in Rats Through a Postsynaptic Alpha2 Adrenergic Receptor

Ira S. Segal, Ross G. Vickery, John K. Walton et al. · Anesthesiology · 1988 · 222 citations · Full text

Molecular Pharmacology, Anaesthetic Agent, Adenosine Receptors +13

SH3 Binding Domains in the Dopamine D4 Receptor

John Oldenhof, Ross G. Vickery, Mordechai Anafi et al. · Biochemistry · 1998 · 101 citations

Molecular Pharmacology, Signal Transduction, Biochemistry +14

The Pharmacology of TD-8954, a Potent and Selective 5-HT4 Receptor Agonist with Gastrointestinal Prokinetic Properties

David T. Beattie, Scott R. Armstrong, Ross G. Vickery et al. · Frontiers in Pharmacology · 2011 · 42 citations · Full text

Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial

Horacio Kaufmann, Ross G. Vickery, Whedy Wang et al. · Clinical Autonomic Research · 2021 · 27 citations · Full text

1–5 of 17